View by Specialty

Trending

DERM0325AAD_Barbieri _Graphic_01
March 13, 2025
4 min read
Save

FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide

Cirrhosis/Liver Failure News

SPONSORED CONTENT
March 18, 2025
2 min read
Save
‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

The addition of simvastatin plus rifaximin to standard therapy did not improve outcomes among patients with decompensated cirrhosis who were at high risk for clinical complications, according to a study published in JAMA.

SPONSORED CONTENT
February 27, 2025
5 min read
Save

Q&A: ‘Unacceptable’ medical deserts leave rural patients with rare diseases stranded

Q&A: ‘Unacceptable’ medical deserts leave rural patients with rare diseases stranded

Approximately 14% of the U.S. population lives in rural areas, where access to health care may be limited by insurance coverage, geography and infrastructure, and provider shortages, according to HHS.

SPONSORED CONTENT
February 26, 2025
2 min read
Save

Metabolic surgery slashed risk for adverse outcomes in MASH-related cirrhosis, obesity

Metabolic surgery slashed risk for adverse outcomes in MASH-related cirrhosis, obesity

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated steatohepatitis, according to study data.

Trending

DERM0325AAD_Barbieri _Graphic_01
March 13, 2025
4 min read
Save

FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide

SPONSORED CONTENT
February 24, 2025
2 min read
Save

FMT safe, linked to reduced hepatic encephalopathy recurrence in patients with cirrhosis

FMT safe, linked to reduced hepatic encephalopathy recurrence in patients with cirrhosis

Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy recurrence among patients with cirrhosis receiving lactulose and rifaximin, according to a study in Journal of Hepatology.

SPONSORED CONTENT
January 07, 2025
2 min read
Save

Hispanic patients with alcohol use disorder face greater odds for hepatitis, cirrhosis

Hispanic patients with alcohol use disorder face greater odds for hepatitis, cirrhosis

Hispanic patients hospitalized for alcohol use disorder were more likely to develop alcohol-associated hepatitis, decompensated cirrhosis and related complications compared with non-Hispanic white patients, according to published data.

SPONSORED CONTENT
December 23, 2024
1 min read
Save

Alfapump implant gains FDA premarket approval for recurrent, refractory cirrhotic ascites

Alfapump implant gains FDA premarket approval for recurrent, refractory cirrhotic ascites

The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of recurrent or refractory ascites due to cirrhosis, according to a company press release.

SPONSORED CONTENT
December 17, 2024
1 min read
Save

FDA fast tracks Lipocine’s oral androgen receptor agonist for sarcopenia in cirrhosis

FDA fast tracks Lipocine’s oral androgen receptor agonist for sarcopenia in cirrhosis

The FDA granted fast track designation to Lipocine’s LPCN 1148, an oral androgen receptor agonist containing testosterone dodecanoate, for the treatment of sarcopenia in patients with decompensated cirrhosis, according to the manufacturer.

SPONSORED CONTENT
November 27, 2024
2 min read
Save

MELD 3.0 reduces sex-based disparities in liver transplant access, waitlist outcomes

MELD 3.0 reduces sex-based disparities in liver transplant access, waitlist outcomes

SAN DIEGO — Waitlist mortality and liver transplant rates for women appear to more closely align with rates for men after the implementation of MELD 3.0, according to late-breaking data presented at The Liver Meeting.

SPONSORED CONTENT
November 27, 2024
1 min read
Save

HHS removes barriers for HIV-positive organ recipients

HHS removes barriers for HIV-positive organ recipients

HHS adopted a final rule eliminating the requirement that patients with HIV in need of a kidney or liver transplant participate in a clinical study to receive an organ from a donor with HIV, according to an agency press release.

SPONSORED CONTENT
November 20, 2024
4 min watch
Save

VIDEO: Combination tobevibart, elebsiran induces ‘rapid virologic suppression’ in HDV

VIDEO: Combination tobevibart, elebsiran induces ‘rapid virologic suppression’ in HDV

SAN DIEGO — Combination tobevibart and elebsiran led to “profound and rapid virologic suppression” as well as normalization of alanine aminotransferase at week 24 in chronic hepatitis D virus infection, according to preliminary data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails